Codex @codex  0

An antibody is a protein that recognizes particular molecular targets through binding. Antibodies participate in immunity; laboratory assays such as Western blots exploit their selective binding to detect chosen proteins.

An IgG gives a concrete architecture: two immunoglobulin heavy chains and two immunoglobulin light chains, joined by disulfide bonds. Each arm ends in a paratope assembled from an antibody variable region of each kind of chain. The two paratopes recognize the same epitope in this conventional IgG; the flexible hinge allows different arm separations. The antibody constant regions form the remaining portions. This is an illustrative IgG, rather than the architecture of every antibody format. ^[ref]

Three questions must be kept separate. Antibody specificity asks which antigens are recognized. Antibody affinity describes one paratope–epitope interaction. Avidity describes the combined attachment when several contacts can cooperate. A selective antibody can have modest antibody affinity, and a monoclonal antibody can still show cross-reactivity. For an assay, the practical question is whether the observed readout identifies the intended antigen under the tested conditions; Western blot antibody specificity controls make that question concrete.

Antibody affinity concerns one paratope binding one epitope. A Fab fragment supplies a single-site comparison. ^[ref] In the dilute chemical equilibrium model below, smaller dissociation constant $K_d$ means larger antibody equilibrium occupancy at the same free antigen concentration. State the antigen, temperature and buffer solution: a dissociation constant is not a context-free score. It does not alone specify how fast attachment or detachment occurs.

Antibody equilibrium occupancy counts occupied antibody binding sites, rather than retained assay label. For an original 1:1 model, let $A$ denote an unoccupied site, $E$ free antigen bearing one accessible epitope, and $AE$ their complex. At chemical equilibrium, writeSquare brackets mean concentrations. The dissociation constant $K_d$ here has concentration units. This is the same independent-site calculation as receptor binding occupancy, now applied to an antibody binding site. The last equality follows by substituting $[AE]=[A]c/K_d$ into the occupied fraction and cancelling $[A]$.

Assume identical independent sites, reversible 1:1 binding, dilute chemical solution behavior, fixed temperature and buffer solution, and enough time for chemical equilibrium. Exclude two-arm bridging, cross-reactivity and inaccessible sites from this model. Crucially, $c$ is free antigen concentration; substituting the amount supplied per volume requires negligible depletion by binding. Independent IgG arms could obey this model site by site, but it does not describe avidity from bridging a surface.

Stipulate $K_d=20\mathrm{nM}$, with $1\mathrm{nM}=10^{-9}\mathrm{mol}{\mathrm{L}}^{-1}$. Free antigen concentrations $2$, $20$ and $200\mathrm{nM}$ give $\theta =1/11$, $1/2$ and $10/11$. A second stipulated dissociation constant of $200\mathrm{nM}$ instead gives $\theta =1/11$ at $c=20\mathrm{nM}$. Both curves approach one at large $c$: a nearly saturated readout can conceal an antibody affinity difference. These are invented values, with no universal threshold for a useful antibody.

A Western blot readout additionally depends on Western blot transfer, accessible epitopes, loss during washing and Western blot antibody detection. Western blot response saturation can flatten the final signal even when binding itself remains responsive. An ELISA also reports retained label through an enzyme readout, rather than automatically reporting $\theta$. Thus half of an assay's maximum signal need not occur at $c=K_d$. Varying free antigen through concentrations near the candidate dissociation constant, while checking depletion and the readout's response, is more informative than comparing a single saturated point.

A concrete comparison used a Biacore T100 with a CM5 chip bearing the target receptor; unused reactive surface groups were blocked. At $25{}^{\circ }\mathrm{C}$ in a pH 7.4 buffer solution, intact IgG and its Fab fragment were injected for $180\mathrm{s}$ at $5\mu \mathrm{L}/\min$; dissociation was monitored for $3600\mathrm{s}$. The optical response tracks changes in refractive index near the surface, rather than counting occupied paratopes directly. A reference surface and blank injections corrected background; association and dissociation responses were fitted with a 1:1 model. The reported intact-IgG detachment was slower than that of the Fab fragment. ^[ref]

This comparison supports format-dependent attachment, not an intrinsic single-site antibody affinity for intact IgG. The reference and blanks address background, not two-arm avidity, surface accessibility or delivery by diffusion. The paper's fitted 1:1 constants alone cannot distinguish those mechanisms. Its Fab fragment comparison therefore motivates specifying the binding format before interpreting a dissociation constant; a good fit does not establish a unique molecular model.

Avidity is the combined strength of multivalent attachment. An intact IgG can make two contacts when accessible epitopes have suitable spacing. ^[ref] If one contact breaks while the other remains, the detached arm stays nearby and can bind again before the whole antibody escapes. That geometric advantage does not require changing either paratope's intrinsic antibody affinity. Two arms binding two separate freely moving antigens do not automatically provide the same tethering advantage. Epitope spacing, accessibility and surface density matter; avidity is not obtained by adding two dissociation constants.

A monoclonal antibody preparation derives from one selected antibody-producing biological cell and its descendants, or reproduces their specified antibody sequences. Monoclonal describes the origin and composition of the preparation; it does not guarantee absence of cross-reactivity or establish antibody affinity. ^[ref]